Comparison tool
Compare peptides
Pick up to three compounds. Useful for deciding whether two peptides in a stack actually do different things, or whether you're paying twice for the same pathway.
Select up to three (1/3)
| Attribute | |
|---|---|
| Category | Growth hormone |
| Evidence grade | Moderate |
| Also known as | NNC 26-0161 |
| Mechanism | Acts as a ghrelin receptor (GHS-R1a) agonist on the pituitary, triggering a clean GH pulse. Its selectivity avoids the appetite and cortisol effects seen with older secretagogues like GHRP-6. |
| Key benefits | Clean GH pulse without hunger spikes · Better sleep quality and recovery · Mild fat-loss and body-composition support |
| Side effects | Mild headache · Injection-site redness · Light-headedness shortly after dosing |
| Half-life | About 2 hours |
| Administration | Subcutaneous injection, 1–3 times daily |
| Dosing overview | 200–300 mcg per dose, often 100–300 mcg before bed |
| Storage | Reconstituted vials refrigerated 2–8 °C, stable ~4 weeks |
| Legal status | Not FDA-approved; compounding restrictions apply in the US. Banned in sport. |
Dosing figures reflect published literature and commonly reported community protocols. They are informational only.